PHARMACOLOGY IS RELEVANT

被引：7

作者：

GIANNI, L

机构：

来源：

ANNALS OF ONCOLOGY | 1993年 / 4卷 / 06期

关键词：

D O I：

10.1093/oxfordjournals.annonc.a058552

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：463 / 465

页数：3

共 16 条

[1] DOES CHEMOTHERAPY FULFILL ITS EXPECTATIONS IN CANCER-TREATMENT [J].

BONADONNA, G .

ANNALS OF ONCOLOGY, 1990, 1 (01) :11-21

[2] CARBOPLATIN DOSAGE - PROSPECTIVE EVALUATION OF A SIMPLE FORMULA BASED ON RENAL-FUNCTION [J].

CALVERT, AH ;

NEWELL, DR ;

GUMBRELL, LA ;

OREILLY, S ;

BURNELL, M ;

BOXALL, FE ;

SIDDIK, ZH ;

JUDSON, IR ;

GORE, ME ;

WILTSHAW, E .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) :1748-1756

[3]

COLLINS JM, 1986, CANCER TREAT REP, V70, P73

[4] PHARMACOLOGICALLY GUIDED PHASE-I CLINICAL-TRIALS BASED UPON PRECLINICAL DRUG DEVELOPMENT [J].

COLLINS, JM ;

GRIESHABER, CK ;

CHABNER, BA .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (16) :1321-1326

[5]

COLLINS JM, 1990, CANCER CHEMOTHERAPY, P16

[6]

DEVITA VT, 1983, CANCER, V51, P1209, DOI 10.1002/1097-0142(19830401)51:7<1209::AID-CNCR2820510707>3.0.CO

[7]

2-J

[8]

EGORIN MJ, 1984, CANCER RES, V44, P5432

[9]

GIANNI L, 1929, EUR J CANCER A, V28, P1302

[10] THE IMPACT OF PHARMACOKINETICALLY GUIDED DOSE ESCALATION STRATEGIES IN PHASE-I CLINICAL-TRIALS - CRITICAL-EVALUATION AND RECOMMENDATIONS FOR FUTURE STUDIES [J].

GRAHAM, MA ;

WORKMAN, P .

ANNALS OF ONCOLOGY, 1992, 3 (05) :339-347

← 1 2 →